Your browser doesn't support javascript.
loading
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.
Hatta, Masahiko; Kaibori, Masaki; Matsushima, Hideyuki; Yoshida, Terufumi; Okumura, Tadayoshi; Hayashi, Mikio; Yoshii, Kengo; Todo, Tomoki; Sekimoto, Mitsugu.
Afiliação
  • Hatta M; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
  • Kaibori M; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
  • Matsushima H; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
  • Yoshida T; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
  • Okumura T; Department of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
  • Hayashi M; Research Organization of Science and Technology, Ritsumeikan University, Kusatsu, Shiga, Japan.
  • Yoshii K; Department of Cell Physiology, Institute of Biomedical Science, Kansai Medical University, Hirakata, Japan.
  • Todo T; Department of Medical Statistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Sekimoto M; Division of Innovative Cancer Therapy, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Mol Ther Oncolytics ; 25: 225-235, 2022 Jun 16.
Article em En | MEDLINE | ID: mdl-35615265
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Ther Oncolytics Ano de publicação: 2022 Tipo de documento: Article